Trial Profile
Intermittent Vs Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Goserelin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms FINNPROSTATE Study VII
- 28 Feb 2012 Results presented at the 27th Congress of the European Association of Urology.
- 01 Jan 2010 Primary endpoint 'Time-to-disease-progression' has been met.
- 05 Jun 2009 New trial record.